Literature DB >> 11701940

Long-term changes in collagen formation expressed by serum carboxyterminal propeptide of type-I procollagen and relation to left ventricular function after acute myocardial infarction.

S H Poulsen1, N B Høst, K Egstrup.   

Abstract

The purpose of this study was to investigate the long-term sequential changes in serum levels of the carboxyterminal propeptide of type-I procollagen (s-PICP), which is a marker of type-I collagen synthesis, and to assess its clinical value in relation to left ventricular (LV) function and prognosis following acute myocardial infarction (AMI). Forty-eight consecutive patients with their first AMI and 15 control subjects were studied. Patients with AMI were stratified according to the changes in s-PICP levels between days 1 and 90 (DeltaPICP) and divided into group I with < or =16.0 microg/l or group II with >16.0 microg/l. Patients in group II were characterized by LV dilatation, no improvement in ejection fraction and development of impaired diastolic filling from day 1 to 360, findings which were in contrast to group I. Cox regression analysis identified changes in s-PICP of >16.0 microg/l as an independent predictor of cardiac death or heart failure during follow-up. In conclusion, DeltaPICP relates to long-term changes in LV function and size, and provides prognostic information following AMI. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701940     DOI: 10.1159/000047385

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

1.  Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.

Authors:  Jirmar Radovan; Pelouch Vaclav; Widimsky Petr; Capek Jan; Andel Michal; Prusa Richard; Pechova Martina
Journal:  Mol Cell Biochem       Date:  2006-08-24       Impact factor: 3.396

2.  Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure.

Authors:  Kurt R Daniel; Gretchen Wells; Kathryn Stewart; Brian Moore; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2009 Mar-Apr

Review 3.  Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.

Authors:  Shweta R Motiwala; Hanna K Gaggin
Journal:  Curr Heart Fail Rep       Date:  2016-10

4.  Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho; Begoña López; Otavio R Coelho-Filho; Neal K Lakdawala; Allison L Cirino; Petr Jarolim; Raymond Kwong; Arantxa González; Steven D Colan; J G Seidman; Javier Díez; Christine E Seidman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

Review 5.  Biomarkers: optimizing treatment guidance in heart failure.

Authors:  Michael Böhm; Adriaan A Voors; Jean-Marie Ketelslegers; Stephan H Schirmer; Eva Turgonyi; Peter Bramlage; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2011-07-16       Impact factor: 5.460

6.  Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Mary L Biggs; Luc Djousse; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Sicovick; Russell P Tracy; Kenneth J Mukamal
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-06-24

7.  Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.

Authors:  Patrício Aguiar; Olga Azevedo; Rui Pinto; Jacira Marino; Carlos Cardoso; Nuno Sousa; Damião Cunha; Derralynn Hughes; José Luís Ducla Soares
Journal:  J Am Heart Assoc       Date:  2018-03-13       Impact factor: 5.501

8.  Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease.

Authors:  Shinsuke Hoshino; Sonia Jain; Chisato Shimizu; Samantha Roberts; Feng He; Lori B Daniels; Andrew M Kahn; Adriana H Tremoulet; John B Gordon; Jane C Burns
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-01

9.  Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction.

Authors:  Shinsuke Hoshino; Chisato Shimizu; Sonia Jain; Feng He; Adriana H Tremoulet; Jane C Burns
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.